Estra

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Estra

What is Estra? Defining the Composition and Purpose

Property Description
Active Ingredient Estradiol (17beta-Estradiol)
Common Forms Tablets, patches, gels, injections, vaginal systems
Pharmacological Class Estrogen; Steroid Hormone
General Purpose Hormone replacement
Origin Bioidentical (chemically identical to the natural hormone)

What Type of Medicine is Estra and Its Active Composition?

Estra is a pharmaceutical agent classified as a Steroid Hormone and belongs to the Estrogen pharmacological group, providing the active substance Estradiol (17beta-Estradiol) to the body. Its fundamental role is to function as an Estrogen Receptor Agonist, mimicking the effects of the primary endogenous estrogen. The drug is considered a bioidentical compound because its chemical structure is chemically identical to the hormone naturally produced, primarily by the ovaries. This bioidentical nature is clinically recognized for offering a straightforward, targeted approach to replacement therapy. The active ingredient, Estradiol, is synthesized for pharmaceutical use to ensure consistency and purity, and its primary function is to replace or supplement insufficient hormone levels.


Available Forms and the Estrogen Component

This medication is presented across a wide range of dosage forms to accommodate various patient needs and delivery methods, including oral tablets, transdermal patches, topical gels, and injectable solutions. The primary active component is Estradiol, though some formulations, particularly those intended for intramuscular injection, utilize a prodrug ester such as estradiol valerate or estradiol cypionate. These esters are designed to facilitate slow absorption and prolonged activity, being converted back into active Estradiol by the body. The active compound is bioidentical in nature. This ensures the substance delivered acts precisely as the body's natural hormone would, allowing for flexibility in the route of administration, whether applied to the skin, taken by mouth, or delivered locally.


What is the General Purpose of Estra?

The general purpose of Estra is hormone replacement, specifically to supplement or replace deficient estrogen levels within the body, a condition often termed hypoestrogenism. By providing the necessary Estradiol, the medication helps restore the crucial hormonal balance required for the maintenance of various physiological functions. This replacement action is fundamental to alleviating the disturbances that arise when the body's natural production of this principal estrogen molecule declines.

Regulatory References

  1. WHO ICD-11

What side effects are possible with Estra?

Possible Side Effects and Safety Information

The safety profile of Estra (Estradiol) is formally categorized by regulatory authorities based on the incidence and nature of adverse reactions. This classification separates common, expected effects from serious, less frequent risks.

Commonly Documented Adverse Reactions (Very Common to Common)

The most frequently observed adverse reactions are generally classified as Very Common (ge 1/10) and Common (ge 1/100 to < 1/10). These often involve headache, breast tenderness, nausea, abdominal pain, and changes in vaginal bleeding patterns (e.g., spotting or breakthrough bleeding). For topical forms, application site reactions are also commonly listed. Effects related to fluid retention and mild weight changes are also routinely documented.


Serious System-Organ Safety Risks

Official labeling contains specific warnings regarding serious, less common risks. These include an increased risk of Thromboembolic Events, specifically Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Stroke, and Myocardial Infarction. The risk of Endometrial Cancer is increased when Estra is used without a progestin in women with an intact uterus, and the risk of Breast Cancer is associated with long-term exposure.


Time-Related Safety Patterns and Limitations

The risk of certain events is officially noted to change with exposure duration. For instance, the risk of Venous Thromboembolism is generally highest in the first year of use. Furthermore, the label specifies constraints on use, such as the requirement for progestin co-administration in women with an intact uterus to mitigate the risk of endometrial hyperplasia and carcinoma. Specific warnings also exist regarding the increased risk of probable dementia in women aged 65 years and older.

Overdose and Emergency Response

️ Estra Overdose and When to Seek Help

A suspected Estra (Estradiol) overdose requires immediate attention, as documented in regulatory guidelines. The official overdose profile indicates that acute exposure to an excess quantity of the medication is generally not classified as life-threatening, but it does produce expected signs related to high estrogen levels.


Documented Manifestations and Emergency Action

Category Description Based on Official Labeling
Documented Manifestations Clinical signs typically involve Nausea, Vomiting, Breast Tenderness, Dizziness, and Headache. A common gynecological sign is Withdrawal Bleeding (Metrorrhagia), which may occur after the initial overdose event.
Antidote Status No specific antidote is known for Estradiol overdose; management is constrained to supportive measures.
Immediate Action Required Individuals must seek immediate medical attention or contact a poison control center upon any known or suspected overdose. Treatment requires the Discontinuation of Estra therapy.
Supportive Management The necessary procedure is symptomatic and supportive treatment, often requiring close observation. The effects of transdermal formulations can be rapidly reversed by removing the patch.

Regulatory Guidance Summary

Regulatory documents define the overdose profile by focusing on the reversible, non-life-threatening clinical signs of excess hormone. The required emergency action is universally established as seeking urgent professional medical assistance for monitoring and to ensure the prompt cessation of exposure. The regulatory constraint remains that only symptomatic management can be applied.

Therapeutic Uses of Estra

What Estra Treats: Main Uses and Benefits

Estra is commonly used to address the significant symptomatic burden that arises from estrogen deficiency, a state often associated with menopause, surgical intervention, or premature ovarian failure. The primary therapeutic goal is to manage key symptom domains and provide long-term health support.

The medication is used in situations involving certain distressing symptoms, such as disruptive vasomotor symptoms (e.g., hot flashes and night sweats) and symptoms related to genitourinary atrophy (e.g., vaginal dryness and painful intercourse (dyspareunia)). It is also relevant in addressing deficiency states like hypogonadism or premature ovarian insufficiency (POI), and contributes to the long-term management of bone mineral density.

“The symptomatic relief provided supports the patient during difficult episodes by easing distress and may contribute to improved day-to-day comfort during symptomatic periods.”

In clinical settings where patients experience these moderate to severe manifestations, Estra is applied when symptoms related to systemic imbalance, such as disruptive vasomotor instability, create noticeable physiological strain, and may assist with easing the overall symptom load.


Quick Fact: Relief for Systemic Discomfort Estra is applied when symptoms related to systemic imbalance, such as disruptive vasomotor instability, create noticeable physiological strain, and may assist with easing the overall symptom load.

Regulatory References

  1. NIH MedlinePlus overview of Estrogen Therapy

Eligibility and Restrictions for Use

Who Can and Cannot Use Estra?

Eligibility to use Estra (Estradiol) is strictly defined by government regulatory agencies and is based on a patient’s medical history and current physiological status. The medicine is primarily intended for postmenopausal women and specific adult populations with hormone deficiency states, such as hypogonadism.

Absolute Contraindications

Estra is contraindicated and must not be used by patients who have a history of, or active, arterial or venous thromboembolic disease (e.g., pulmonary embolism, stroke, or deep vein thrombosis). Use is also prohibited for individuals with known, suspected, or a history of estrogen-dependent malignant neoplasia (e.g., breast cancer or endometrial cancer), undiagnosed abnormal uterine bleeding, or active, severe liver disease.

Population and Conditional Restrictions

Estra is contraindicated during known or suspected pregnancy and is generally not recommended for women who are breastfeeding. For women with an intact uterus, Estra use is conditional and requires the mandatory co-administration of a progestogen to mitigate the risk of endometrial changes. Safety and efficacy are generally not established for use in the pediatric population. Close monitoring is required for patients with severe hypertriglyceridemia or severe renal impairment.

What should I know about interactions with other medicines?

Estra, which contains estradiol, can interact with numerous prescription and over-the-counter medicines, as well as herbal supplements. These interactions can potentially alter the effectiveness of Estra or increase the risk of side effects.

Medicines That Can Decrease Estra's Effect

Certain drugs can speed up the metabolism of estradiol in the liver, leading to lower estrogen levels and potentially reducing Estra's therapeutic benefit. Examples include:

  • Anticonvulsants: Such as phenobarbital and carbamazepine.
  • Antibiotics: Such as rifampin.
  • Herbal products: Notably St. John's Wort.

Medicines That May Increase Estra's Effects

Conversely, some medications can slow down the breakdown of estradiol, which may increase the concentration of Estra in the body and heighten the risk of side effects. These include certain antifungal drugs (e.g., ketoconazole) and antibiotics (e.g., erythromycin, clarithromycin).

Interactions Affecting Other Medications

Estra may also interfere with the effectiveness of other drugs, such as medications for thyroid hormone replacement (e.g., levothyroxine) and the anti-seizure medication lamotrigine.

Food and Lifestyle Considerations

  • Grapefruit Juice can interfere with the metabolism of Estra, which may lead to increased estrogen levels.
  • Smoking significantly increases the risk of serious cardiovascular side effects (blood clots, stroke) when using estrogen-containing products like Estra. This combination should be avoided.

Always provide your healthcare provider with a complete list of all medications, vitamins, and herbal supplements you are taking before starting or while on Estra therapy.

Mechanism of Action

Estra, referring to a pharmacologically active estradiol moiety, functions as an agonist at the Estrogen Receptors (ERs), specifically the nuclear ER-alpha (ERalpha) and ER-beta (ERbeta), which are predominantly expressed in reproductive tissues, bone, and the central nervous system. Upon ligand binding, Estra induces a conformational change in the receptor. This activated receptor-ligand complex dimerizes and translocates to the cell nucleus, where it binds to specific DNA sequences known as Estrogen Response Elements (EREs) located in the promoter regions of target genes. This binding event modulates gene transcription, either activating or repressing the expression of downstream genes involved in cell proliferation, differentiation, and tissue maintenance.

The resulting intracellular cascade leads to a system-level physiological modulation by replicating the effects of endogenous 17beta-estradiol, principally regulating the negative feedback loop on the hypothalamic-pituitary-gonadal axis, thereby suppressing the secretion of gonadotropins such as Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).

Dosage and Administration Information

How to Use Estra

The administration of Estra, which contains Estradiol, follows established procedural standards to ensure standardized application and dosing. The medication is delivered via several approved routes, including oral ingestion, transdermal application (patches and gels), vaginal insertion (creams or tablets), and intramuscular injection using esterified forms for depot action.


Dosing and Frequency Patterns

Standard clinical guidelines emphasize the principle of utilizing the lowest effective dose for the shortest duration necessary, with the necessity for continued therapy subject to re-evaluation at periodic intervals. Dosage ranges are defined by the formulation: for instance, oral tablets are typically administered once daily in doses ranging from 0.5 mg to 2 mg, while transdermal patches deliver a continuous release rate, typically starting from 0.025 mg/day and are replaced either once or twice weekly. For injectable solutions, the dose is administered at extended intervals, such as every three to four weeks.


Special Administration Requirements

A critical procedural requirement for Estra use in patients with an intact uterus is the mandatory co-administration of a progestin for at least 12 to 14 days per cycle. This requirement is part of the established administration protocol. In transdermal use, the application site must be routinely rotated to ensure proper absorption. If a dose of the oral formulation is missed by a significant margin (e.g., more than 12 hours), the procedural instruction is generally to skip the forgotten dose and resume the regular daily schedule. Certain high-strength vaginal formulations carry a distinct restriction, limiting their use to a single treatment period of no more than four weeks.

Recent Clinical Evidence

Research evidence / Overview of Studies for Estra

This section provides a summary of the clinical research conducted on Estra (Estradiol), focusing on the types of studies that have been completed and what researchers monitored. The intent is to describe the evidence landscape in a neutral, patient-friendly manner, consistent with authoritative scientific and regulatory sources.


Evidence from Studies on Vasomotor Symptoms

Estra was studied for its effect on vasomotor symptoms, which includes frequent hot flashes and night sweats, and has largely relied on short-term Randomized Controlled Trials (RCTs). Researchers monitored changes in the daily frequency and severity of these episodic manifestations. Findings from these short-term trials describe patterns observed in the studies, where administration of Estra was studied for its relationship to symptom patterns in the observed populations.

What remains uncertain is the full characterization of long-term outcomes, as many of the foundational efficacy studies were short-term. Furthermore, data for long-term health outcomes often comes from large observational cohorts, meaning results apply only to the populations studied.


Evidence from Studies on Bone Health and Mineral Density

Estra was studied in the context of bone mineral density (BMD) in populations who experience low estrogen states, primarily postmenopausal women at risk of osteoporosis. Research employed intermediate-term RCTs (lasting one to two years) to monitor changes in a surrogate endpoint: Bone Mineral Density (BMD). Larger, longer-running observational studies also monitored the definitive outcome of fracture incidence over many years.

Studies monitored physiological changes related to the bone remodeling process, and data show patterns related to BMD changes in the observed populations. The evidence for fracture outcomes over the long term is a key focus of regulatory attention, though some of the long-term data comes from studies where the women used combination hormonal therapies. While BMD provides short-term insight, long-term effects on fracture incidence are not fully established in all contexts.


Scientific Gaps and Areas of Uncertainty

Research limitation frames include instances where follow-up durations were limited for certain key endpoints, particularly concerning the durability of observed changes after treatment is stopped. Data remain limited for certain delivery methods and specific age groups outside of the primary postmenopausal population. Because the studies describe group patterns, the research does not determine whether an individual will respond similarly, and certainty remains low regarding the long-term application of findings to individuals with complex, pre-existing comorbidities.

Key Studies & References

  1. Guideline: Management of Menopause-Related Symptoms (Summary of evidence for VMS and GSM)
  2. Evidence on the long-term effects of hormone therapy: WHI findings and follow-up data (Supporting long-term and observational context)
  3. Systematic review of treatments for Genitourinary Syndrome of Menopause (GSM) (Supporting Genitourinary evidence)

Frequently Asked Questions (FAQ)

Common questions about Estra (FAQ)

Q: Why is Estra prescribed to so many different people?

A: Estra is approved by regulatory bodies for several distinct uses related to hormone deficiency. According to official product information, these uses include treating moderate-to-severe vasomotor symptoms (hot flashes), addressing moderate-to-severe vulvar and vaginal atrophy, and preventing postmenopausal osteoporosis. It is also used to treat specific hormone deficiency states.

Q: How quickly should I expect to feel the effects of Estra?

A: The precise timing for when therapeutic effects are felt is not typically detailed in general patient labeling. However, official pharmacokinetics data (how the body handles the drug) show that the elimination half-life varies based on the formulation (e.g., oral, patch, injection). This suggests that the body reaches a stable level of the medicine over several dosing intervals.

Q: What happens if I accidentally take two doses of Estra close together?

A: Taking too much Estra (an overdose) can potentially lead to symptoms such as nausea, vomiting, or abnormal vaginal bleeding. Official regulatory advice for a missed dose is generally to resume your regular schedule and not to take extra doses to compensate. Concerns about taking too much medication should be addressed with a healthcare provider.

Q: How long does Estra stay in your system after stopping it?

A: The length of time Estra stays in your system depends heavily on the specific form of the medicine you are using. The active ingredient, Estradiol, has an elimination half-life that ranges from approximately 13 to 20 hours for oral tablets but can be several days for specialized injectable forms. This half-life determines how long it takes for the drug to be substantially cleared from the body.

Q: Can Estra affect my mood or cause anxiety?

A: Yes, regulatory documents list potential psychological and central nervous system effects. Some hormonal products containing estradiol may include mood changes, depression, or anxiety as possible adverse reactions. Any concerns regarding changes in mood or mental health are best discussed with a healthcare professional.

Q: What is the difference between Estra and other common similar medications?

A: Estra contains Estradiol, which is a bioidentical compound, meaning its chemical structure is identical to the main estrogen naturally produced by the human body. Other similar hormonal medicines may utilize different estrogen compounds (like conjugated estrogens) or are combinations of estrogen and progestin.

Q: Do I need to take Estra with food, or can I take it on an empty stomach?

A: For the oral tablet form, the official regulatory instruction is to take the medication at the same time every day. This consistency is key. The label generally indicates that the tablets may be taken with or without food.

Q: Can Estra make my skin more sensitive to the sun?

A: Official adverse reaction lists mention skin effects like chloasma or melasma (dark patches on the skin). Regulatory information states that these patches are often exacerbated by sun exposure. Many healthcare providers advise the use of sun protection when taking medications that increase skin sensitivity.

Q: Is Estra safe for people with high blood pressure?

A: Regulatory labeling indicates that Estra can potentially cause an increase in blood pressure in certain patients. For this reason, official guidance recommends that blood pressure should be monitored at regular intervals while using the medication.

Q: Can men also take Estra, and for what reasons?

A: Yes, official product information confirms that Estra is approved for use in men. The approved reasons include the relief of symptoms from advanced androgen-dependent carcinoma of the prostate and certain cases of metastatic breast cancer.

Q: Why do doctors recommend taking Estra at the same time every day?

A: Taking the medication at a consistent time is a standard instruction for oral formulations. This is recommended to help maintain stable blood levels of estradiol throughout the day. Maintaining consistent blood levels is important for ensuring the medication’s intended therapeutic effect is reliable.

Q: Does Estra affect fertility or planning to conceive?

A: Official labeling states that Estradiol can have anti-gonadotropic effects, which means it can suppress sex hormone production and may inhibit fertility in both women and men. Furthermore, the medicine is contraindicated and must not be used during known or suspected pregnancy.

Q: Is Estra a lifelong medication, or is it typically used short-term?

A: Regulatory guidance emphasizes the principle of using the lowest effective dose for the shortest duration necessary for treatment goals. The need for continued therapy is typically subject to periodic re-evaluation by the prescribing healthcare provider, and some formulations have maximum treatment timeframes.

Q: Is it okay to stop Estra suddenly, or do I need to taper off?

A: Official regulatory documents indicate that when estrogen therapy is stopped, some therapeutic benefits, such as bone mass maintenance, may decline. Cessation of the medication is a decision that is best discussed with and managed by a healthcare provider.

Q: Why do some people experience initial headaches when starting Estra?

A: Headache is listed in official documents as a very common to common adverse reaction when taking Estra. While the exact patient-level explanation is not provided in all regulatory documents, the effect is recognized to be linked to the hormonal and central nervous system modulation caused by the medication.

Q: Can Estra affect my sleep patterns?

A: Adverse reaction profiles listed in regulatory documents include sleep problems, such as insomnia. This is categorized under the known central nervous system effects of the medication. Any disruptive changes to sleep patterns are best reviewed with a healthcare provider.

Q: Are people with a history of liver issues able to safely use Estra?

A: Active, severe liver disease is a contraindication for Estra, meaning its use is contraindicated and should be strictly avoided. Since estrogens are primarily metabolized by the liver, official warnings state that patients with impaired liver function or a history of certain liver conditions must use the medicine with caution and close monitoring.

Q: Can Estra cause changes to my appetite?

A: While a general change in appetite is not uniformly listed in common side effects, adverse reaction profiles frequently mention gastrointestinal effects like nausea and vomiting. In the event of a rare serious side effect like severe liver injury, a loss of appetite may be an associated symptom to watch for.

Q: Does Estra have any known interactions with other prescription medications like antidepressants?

A: Official information indicates that Estra is known to interact with medicines that affect certain liver enzymes, such as the CYP450 system. Since many types of drugs, including some antidepressants, are metabolized by this system, an interaction is possible. Providing a complete list of all medications to the prescribing healthcare provider is a critical step before starting therapy.

Q: Does Estra help with symptoms other than the primary condition it treats?

A: Estra is approved for multiple specific indications, such as treating hot flashes. The regulatory documents confirm that its estrogen replacement action is also approved for purposes like prevention of postmenopausal osteoporosis and the treatment of vulvar/vaginal atrophy. These may be secondary benefits depending on your primary reason for use.

Q: Why is Estra sometimes prescribed in combination with other drugs?

A: Estra is mandatorily prescribed in combination with a progestin for patients who still have an intact uterus. This is a critical safety measure required by regulatory bodies, as it significantly reduces the risk of developing endometrial hyperplasia and carcinoma (cancer of the uterine lining).

Q: Does Estra interact with oral contraceptives or other hormonal birth control?

A: Estra itself is an estrogen, and using it with other hormonal therapies, especially those that also contain estrogen, is generally contraindicated by regulatory guidance. This is due to the potential for excessive systemic estrogen exposure and a resulting heightened risk of serious side effects.

How should Estra be stored and disposed of?

How to Store and Dispose of Estradiol (Estra)

Official regulatory guidelines dictate specific conditions to maintain the stability of Estradiol (Estra) formulations.


Storage Requirements

Most Estra products must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), and must not be frozen. The medication should be kept in its original, tightly closed container and protected from excessive heat and moisture.

For safety, Estradiol must be kept out of the reach and sight of children.


Disposal Instructions

Unused or expired Estradiol should be disposed of via an official drug take-back program. If one is unavailable, follow household disposal procedures that typically involve mixing the drug with an undesirable substance. Do not flush the medication down a toilet or pour down a drain. Used transdermal patches must be folded in half, sticky sides together, before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Estra found in:

A-Z Index: